Findlay, A., Turner, C., Schilter, H., Deodhar, M., Zhou, W., Perryman, L., . . . Jarolimek, W. (2021). An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies. Wiley.
Style de citation Chicago (17e éd.)Findlay, Alison, et al. An Activity‐based Bioprobe Differentiates a Novel Small Molecule Inhibitor from a LOXL2 Antibody and Provides Renewed Promise for Anti‐fibrotic Therapeutic Strategies. Wiley, 2021.
Style de citation MLA (8e éd.)Findlay, Alison, et al. An Activity‐based Bioprobe Differentiates a Novel Small Molecule Inhibitor from a LOXL2 Antibody and Provides Renewed Promise for Anti‐fibrotic Therapeutic Strategies. Wiley, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.